Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

ANALYST RECOMMENDATION BOOSTS SYGN

March 19, 1992

AGRACETUS LICENSES COTTON TECHNOLOGY

March 19, 1992

BLOOD SUBSITUTE SHOWS EARLY PROMISE

March 19, 1992

GENZYME HA MEMBRANE ENTERS CLINIC

March 19, 1992

INSITE GETS SBIR TO SCALE UP DRUG

March 19, 1992

QUADRA LOGIC ADOPTS POISON PILL

March 19, 1992

LTIZ RAISES $32M FOR CANCER PROGRAMS

March 19, 1992

LICENSING STRATEGY ATTRACTS $22.4 M IN IPO

March 19, 1992

SYNTHETIC TAXOL 'EXCITINGLY CLOSE'

March 18, 1992

COMPANY DEFECTS TO NEW AMEX MARKET

March 18, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...